Proteomics International Laboratories has received a milestone seal of approval for its...
Supplementary Prospectus issued
PILL has issued a Supplementary Prospectus following execution of an agreement to commercialise its diabetic kidney disease diagnostic test in China and reduced its minimum subscription to $3 million.